Anglo Irish Bank Corporation Act 2009

Recce Pharmaceuticals Secures $8M Placement and Launches $3M Entitlement Offer to Shareholders

Retrieved on: 
Wednesday, September 13, 2023

“We are thrilled to receive such strong financial interest, particularly among global investment funds,” said James Graham, Chief Executive Officer of Recce Pharmaceuticals.

Key Points: 
  • “We are thrilled to receive such strong financial interest, particularly among global investment funds,” said James Graham, Chief Executive Officer of Recce Pharmaceuticals.
  • Each of the Directors of the Company intends to subscribe for their respective entitlement partially or in full under the entitlement offer.
  • Any new shares not applied for under the entitlement offer and any entitlements that would have been offered to ineligible shareholders if they had been entitled to participate in the offer will form part of the shortfall from the entitlement offer.
  • Further information in relation to the entitlement offer will be sent to eligible shareholders in the offer booklet and accompanying personalized entitlement and acceptance form, which are expected to be dispatched on Friday, September 15, 2023.

SECURITY MATTERS LIMITED Announces Business Combination With LIONHEART III CORP (LION)

Retrieved on: 
Tuesday, July 26, 2022

SMX CEO Haggai Alon commented: SMX is thrilled to join Lionheart in our entry into the US public market.

Key Points: 
  • SMX CEO Haggai Alon commented: SMX is thrilled to join Lionheart in our entry into the US public market.
  • Ophir Sternberg, CEO and Founder of Lionheart Capital, commented: Lionheart is honored to welcome SMX to our portfolio of diverse and exciting business endeavors.
  • EF Hutton, a division of Benchmark Investments, LLC, is serving as financial advisor to Lionheart III Corp. K&L Gates, Afik & Co Attorneys & Notary and Arthur Cox LLP are serving as legal counsel to SMX.
  • DLA Piper is serving as legal counsel to Lionheart III Corp. Futerra will act as SMXs global brand strategy agency.